Medical Device ABM Agency

Target Account Lists

ABM starts with a list, not a funnel. We name the specific hospitals, health systems, and IDNs worth winning, scored on firmographic and clinical fit: procedure volume in your device category, existing technology footprint, and how their procurement is structured. A single academic medical center and a regional community hospital buy the same device on completely different timelines and committees, so the list is built around how each account actually decides.

The output is a ranked set of named accounts your sales team recognizes, not an anonymous audience segment. That shared list is what lets marketing and sales work the same targets instead of talking past each other.

Intent Data

Once the list exists, intent data tells you which of those accounts are researching a solution like yours right now. We layer signals from review sites, search behavior, and content engagement to surface the accounts moving from passive to active, so outreach lands when a committee is actually forming rather than months before or after.

Intent does not replace judgment, it prioritizes it. We use it to decide which named accounts get the full orchestrated play this quarter and which stay in nurture, so the team spends its hours where a purchase decision is genuinely in motion.

Orchestration Across the Long Sales Cycle

Device buying runs 12 to 18 months and touches multiple people, so a one-off campaign does nothing. We orchestrate multi-touch sequences across email, LinkedIn, paid media, and conference field plays, mapped to the committee members inside each account: the surgeon champion, biomedical engineering, value analysis, and procurement.

Each touch is timed to where the account sits in its cycle, and every channel points at the same named accounts, so a booth conversation, a LinkedIn message, and a paid impression reinforce one another instead of running as separate programs.

Committee Buying, Not a Single Decision-Maker

A device rarely gets bought by one person. The surgeon champion wants the clinical case, biomedical engineering wants integration and service, value analysis wants the cost story, and procurement wants terms. Generic ABM built for software assumes an economic buyer and a champion. Medtech ABM has to speak to four or five roles with different questions, and the content plan has to give each of them something credible without overstepping FDA promotional limits.

Claim Discipline Inside the Program

ABM content still lives under FDA promotional rules. Every asset in the sequence, from a LinkedIn message to a gated clinical summary, has to stay inside cleared indications and avoid off-label promotion. We have run device marketing for over 15 years, so claim review is built into the ABM workflow rather than bolted on after legal flags a sequence that already shipped.

Conference-Anchored Account Plays

Many device deals advance at a show, so our ABM programs treat the conference calendar as a core channel, not a separate line item. We time pre-show outreach, on-site meetings, and post-show follow-up to the named accounts in the program, which ties the field motion directly to the accounts you are trying to move.

ABM works best as one motion inside a full commercial program, not as an island. The target account list sharpens who your medical device PPC should reach, your healthcare SEO makes sure those accounts find credible answers when they research you, and your conference marketing gives the field plays somewhere to happen. For the full commercial picture, see our medical device marketing agency overview.

We run these together with one team, so the account list, the paid targeting, the search footprint, and the field calendar all point at the same named accounts instead of drifting apart across vendors.